Cormedix Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of Cormedix Inc.'s 2015 annual meeting of stockholders held on June 4, 2015. The filing details the election of directors, advisory votes on executive compensation, and the ratification of the independent auditor.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and voting results.
Material Changes and Voting Results
Seven directors were elected to the Board of Directors for a term expiring in 2016. All nominees received significant majority support:
- Steven Lefkowitz & Antony E. Pfaffle, M.D.: Received the highest support with 18,074,919 votes "For" and only 30,527 "Withheld."
- Cora M. Tellez: Received 17,959,318 votes "For" and 146,128 "Withheld."
- Other Directors (Duffy, George, Markvicka, Milby): Received between 17,197,509 and 17,288,779 votes "For," with withheld votes ranging from 816,667 to 907,937.
- Broker Non-Votes: Zero broker non-votes were recorded for the director elections.
Regarding executive compensation:
- 2014 Compensation Approval: Stockholders approved the 2014 executive compensation with 17,747,326 votes "For" and 276,606 "Against."
- Frequency of Future Votes: Stockholders voted to hold future advisory votes on executive compensation once every three years (13,690,673 votes), rather than annually (3,334,084 votes) or biennially (886,047 votes). The Company will follow this recommendation.
Stockholders ratified the appointment of Friedman LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2015, with 18,093,776 votes "For" and 11,670 "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the composition of the newly elected Board of Directors and their terms.
- Confirm the Company's commitment to triennial executive compensation advisory votes based on the shareholder mandate.
- Review the full proxy statement for details on the specific executive compensation packages approved.
- Check subsequent filings for the Company's financial performance, as this 8-K contains no financial data.